# Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers

> **NCT06966232** · PHASE3 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 136 (estimated)

## Conditions studied

- Gastrointestinal Cancers

## Interventions

- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT06966232
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-15
- **Primary completion:** 2027-05-15
- **Final completion:** 2027-05-20
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2025-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06966232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06966232, "Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06966232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*